Corrigendum to "Analysis of central nervous system efficacy in the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer" [Lung Cancer 121 (July) (2018) Pages 37-40]

Affiliations

• ¹ Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo 135-8550, Japan. Electronic address: mnishio@jfcr.or.jp.
• ² Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan.
• ³ Department of Surgery, Division of Thoracic Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan.
• ⁴ Third Department of Internal Medicine, Wakayama Medical University, Kimiidera, Wakayama 641-8509, Japan.
• ⁵ Clinical Science & Strategy Department, Chugai Pharmaceutical Co. Ltd, Chuo-ku, Tokyo 103-8324, Japan.
• ⁶ F. Hoffmann-La Roche Ltd, Basel, Switzerland.
• ⁷ Thoracic Center, St. Luke's International Hospital, Chuo-ku, Tokyo 104-8560 Japan.